Imagine the relief of a parent, waking up to the news that their child’s life-changing medication is now free. This isn’t a dream; it’s reality for hundreds of Maltese families. The Maltese government has just announced the addition of 15 new epilepsy medicines to the list of free medications, a move that’s set to significantly improve the quality of life for many.

Epilepsy affects around 1 in 100 people in Malta, according to the Malta Epilepsy Association. The condition can be life-altering, causing unpredictable seizures that can hinder daily activities and social interactions. The cost of medication can also be a significant burden, with some families spending hundreds of euros each month.

Now, thanks to the government’s initiative, 15 new antiepileptic drugs will be available free of charge. This includes medicines like Perampanel, Lacosamide, and Brivaracetam, which are often prescribed when first-line treatments fail. These drugs can be game-changers, reducing seizure frequency and improving quality of life.

“This is a massive step forward,” says Dr. Joseph Cuschieri, a neurologist at Mater Dei Hospital. “We’ve been advocating for better access to these drugs for years. Now, we can finally offer our patients the best possible care without the financial burden.”

To access the free medicines, patients will need a prescription from their neurologist. The prescription should be taken to any of the island’s pharmacies, where the medication will be dispensed free of charge. No co-payment is required, making it a truly free service.

For those living in rural areas or finding it difficult to travel, the government has also ensured that the medicines are available at all health centers. This includes centers in towns like Żebbuġ, Dingli, and Xewkija, making it easier for everyone to access the free medicines.

While this is a significant victory for Maltese families affected by epilepsy, there’s still more work to be done. The Malta Epilepsy Association is now calling for better awareness and understanding of the condition, as well as improved access to specialist care.

Dr. Cuschieri echoes this sentiment, “While these new medicines are a huge step forward, we still need to improve our understanding of epilepsy. We need to ensure that everyone, from teachers to employers, understands the condition and how to support those living with it.”

As we look to the future, let’s hope that this is just the beginning. Let’s hope that this move signals a new era of improved care and understanding for those living with epilepsy in Malta.